Publications:

---

NGS-based targeted gene mutational profiles in Korean patients with pancreatic cancer.

Scientific Reports

Jung, Kwangrok K; Lee, Sejoon S; Na, Hee Young HY; Kim, Ji-Won JW; Lee, Jong-Chan JC; Hwang, Jin-Hyeok JH; Kim, Jin Won JW; Kim, Jaihwan J

Publication Date: 2022-12-03

Variant appearance in text: KRAS: 113A>C

PubMed Link: 36463295

Variant Present in the following documents:

• 41598_2022_24732_MOESM1_ESM.xlsx, sheet 5

View BVdb publication page

---

AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis.

Nature Communications

Kim, Dae Gyu DG; Choi, Yongseok Y; Lee, Yuno Y; Lim, Semi S; Kong, Jiwon J; Song, JaeHa J; Roh, Younah Y; Harmalkar, Dipesh S DS; Lee, Kwanshik K; Goo, Ja-Il JI; Cho, Hye Young HY; Mushtaq, Ameeq Ul AU; Lee, Jihye J; Park, Song Hwa SH; Kim, Doyeun D; Min, Byung Soh BS; Lee, Kang Young KY; Jeon, Young Ho YH; Lee, Sunkyung S; Lee, Kyeong K; Kim, Sunghoon S

Publication Date: 2022-05-11

Variant appearance in text: KRAS: D38A

PubMed Link: 35546148

Variant Present in the following documents:

• 41467_2022_30149_MOESM1_ESM.pdf

View BVdb publication page

---

RAS interaction with Sin1 is dispensable for mTORC2 assembly and activity.

Proceedings Of The National Academy Of Sciences Of The United States Of America

Castel, Pau P; Dharmaiah, Srisathiyanarayanan S; Sale, Matthew J MJ; Messing, Simon S; Rizzuto, Gabrielle G; Cuevas-Navarro, Antonio A; Cheng, Alice A; Trnka, Michael J MJ; Urisman, Anatoly A; Esposito, Dominic D; Simanshu, Dhirendra K DK; McCormick, Frank F

Publication Date: 2021-08-17

Variant appearance in text: KRAS: D38A

PubMed Link: 34380736

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Structural Insights into the SPRED1-Neurofibromin-KRAS Complex and Disruption of SPRED1-Neurofibromin Interaction by Oncogenic EGFR.

Cell Reports

Yan, Wupeng W; Markegard, Evan E; Dharmaiah, Srisathiyanarayanan S; Urisman, Anatoly A; Drew, Matthew M; Esposito, Dominic D; Scheffzek, Klaus K; Nissley, Dwight V DV; McCormick, Frank F; Simanshu, Dhirendra K DK

Publication Date: 2020-07-21

Variant appearance in text: KRAS: D38A

PubMed Link: 32697994

Variant Present in the following documents:

• Main text
• nihms-1613940.pdf

View BVdb publication page

---

Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration.

Nature Communications

Shin, Seung-Min SM; Choi, Dong-Ki DK; Jung, Keunok K; Bae, Jeomil J; Kim, Ji-Sun JS; Park, Seong-Wook SW; Song, Ki-Hoon KH; Kim, Yong-Sung YS

Publication Date: 2017-05-10

Variant appearance in text: KRAS: D38A

PubMed Link: 28489072

Variant Present in the following documents:

• ncomms15090.pdf

View BVdb publication page

---

Multivalent Small-Molecule Pan-RAS Inhibitors.

Cell

Welsch, Matthew E ME; Kaplan, Anna A; Chambers, Jennifer M JM; Stokes, Michael E ME; Bos, Pieter H PH; Zask, Arie A; Zhang, Yan Y; Sanchez-Martin, Marta M; Badgley, Michael A MA; Huang, Christine S CS; Tran, Timothy H TH; Akkiraju, Hemanth H; Brown, Lewis M LM; Nandakumar, Renu R; Cremers, Serge S; Yang, Wan Seok WS; Tong, Liang L; Olive, Kenneth P KP; Ferrando, Adolfo A; Stockwell, Brent R BR

Publication Date: 2017-02-23

Variant appearance in text: KRAS: D38A

PubMed Link: 28235199

Variant Present in the following documents:

• Main text

View BVdb publication page

---